Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
<h4>Background</h4>Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The aim of the present study was to determine whether circulating soluble TIM3 (sTIM3) is elevated in patients wi...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0238540 |
id |
doaj-5b22f2ff2b9142a79bc8da3effb54bb2 |
---|---|
record_format |
Article |
spelling |
doaj-5b22f2ff2b9142a79bc8da3effb54bb22021-03-04T12:45:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011512e023854010.1371/journal.pone.0238540Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.Kiyoshi MigitaMinoru NakamuraYoshihiro AibaHideko KozuruSeigo AbiruAtsumasa KomoriYuya FujitaJunpei TemmokuTomoyuki AsanoShuzo SatoMakiko FuruyaAtsushi NaganumaKaname YoshizawaMasaaki ShimadaKeisuke ArioTomohiko MannamiHiroshi KohnoToshihiko KaneyoshiTakuya KomuraHiromasa OhiraHiroshi Yatsuhashi<h4>Background</h4>Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The aim of the present study was to determine whether circulating soluble TIM3 (sTIM3) is elevated in patients with AIH patients and whether sTIM-3 levels are associated with clinical parameters of AIH.<h4>Methods</h4>We enrolled 123 Japanese patients with AIH who were identified from the National Hospital Organization-AIH-liver-network database, as well as 32 patients with chronic hepatitis C (CHC), 30 patients with primary biliary cholangitis (PBC) and healthy control subjects. Serum sTIM-3 concentrations were quantified by ELISA.<h4>Results</h4>Serum levels of sTIM-3 were significantly higher in AIH patients (median 4865 pg/ml; [interquartile range (IQR); 3122-7471]) compared to those in CHC (1026 pg/ml [IQR: 806-1283] p<0.001), PBC (2395 pg/ml [IQR: 2012-3422] p<0.001) or healthy controls (1285 pg/ml [IQR: 1098-1812] p<0.001). In AIH group, serum sTIM-3 were correlated with alanine aminotransferase (ALT), or total bilirubin (TB) and negatively correlated with serum levels of albumin (Alb). Serum levels of sTIM-3 were also strongly correlated with Mac-2 binding protein glycosylation isomer (M2BPGi) levels, but did not correlate with the histological grade of liver fibrosis. Steroid treatment of AIH patients significantly reduced serum sTIM-3 levels (2147±623pg/ml versus 1321±378pg/ml, p<0.001).<h4>Conclusions</h4>Circulating sTIM-3 levels were elevated in AIH patients and are associated with AIH disease activity and AIH-related liver damage. These findings indicate that serum sTIM-3 correlated with disease status of AIH and could be useful biomarkers to detect autoimmune-mediated liver injury. Our data suggest a possible link between the TIM-3/GAL-9 pathway and AIH severity or phenotype, and further investigations of the TIM-3 pathway and AIH pathophysiology is warranted.https://doi.org/10.1371/journal.pone.0238540 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kiyoshi Migita Minoru Nakamura Yoshihiro Aiba Hideko Kozuru Seigo Abiru Atsumasa Komori Yuya Fujita Junpei Temmoku Tomoyuki Asano Shuzo Sato Makiko Furuya Atsushi Naganuma Kaname Yoshizawa Masaaki Shimada Keisuke Ario Tomohiko Mannami Hiroshi Kohno Toshihiko Kaneyoshi Takuya Komura Hiromasa Ohira Hiroshi Yatsuhashi |
spellingShingle |
Kiyoshi Migita Minoru Nakamura Yoshihiro Aiba Hideko Kozuru Seigo Abiru Atsumasa Komori Yuya Fujita Junpei Temmoku Tomoyuki Asano Shuzo Sato Makiko Furuya Atsushi Naganuma Kaname Yoshizawa Masaaki Shimada Keisuke Ario Tomohiko Mannami Hiroshi Kohno Toshihiko Kaneyoshi Takuya Komura Hiromasa Ohira Hiroshi Yatsuhashi Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis. PLoS ONE |
author_facet |
Kiyoshi Migita Minoru Nakamura Yoshihiro Aiba Hideko Kozuru Seigo Abiru Atsumasa Komori Yuya Fujita Junpei Temmoku Tomoyuki Asano Shuzo Sato Makiko Furuya Atsushi Naganuma Kaname Yoshizawa Masaaki Shimada Keisuke Ario Tomohiko Mannami Hiroshi Kohno Toshihiko Kaneyoshi Takuya Komura Hiromasa Ohira Hiroshi Yatsuhashi |
author_sort |
Kiyoshi Migita |
title |
Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis. |
title_short |
Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis. |
title_full |
Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis. |
title_fullStr |
Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis. |
title_full_unstemmed |
Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis. |
title_sort |
association of soluble t cell immunoglobulin domain and mucin-3 (stim-3) and mac-2 binding protein glycosylation isomer (m2bpgi) in patients with autoimmune hepatitis. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2020-01-01 |
description |
<h4>Background</h4>Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The aim of the present study was to determine whether circulating soluble TIM3 (sTIM3) is elevated in patients with AIH patients and whether sTIM-3 levels are associated with clinical parameters of AIH.<h4>Methods</h4>We enrolled 123 Japanese patients with AIH who were identified from the National Hospital Organization-AIH-liver-network database, as well as 32 patients with chronic hepatitis C (CHC), 30 patients with primary biliary cholangitis (PBC) and healthy control subjects. Serum sTIM-3 concentrations were quantified by ELISA.<h4>Results</h4>Serum levels of sTIM-3 were significantly higher in AIH patients (median 4865 pg/ml; [interquartile range (IQR); 3122-7471]) compared to those in CHC (1026 pg/ml [IQR: 806-1283] p<0.001), PBC (2395 pg/ml [IQR: 2012-3422] p<0.001) or healthy controls (1285 pg/ml [IQR: 1098-1812] p<0.001). In AIH group, serum sTIM-3 were correlated with alanine aminotransferase (ALT), or total bilirubin (TB) and negatively correlated with serum levels of albumin (Alb). Serum levels of sTIM-3 were also strongly correlated with Mac-2 binding protein glycosylation isomer (M2BPGi) levels, but did not correlate with the histological grade of liver fibrosis. Steroid treatment of AIH patients significantly reduced serum sTIM-3 levels (2147±623pg/ml versus 1321±378pg/ml, p<0.001).<h4>Conclusions</h4>Circulating sTIM-3 levels were elevated in AIH patients and are associated with AIH disease activity and AIH-related liver damage. These findings indicate that serum sTIM-3 correlated with disease status of AIH and could be useful biomarkers to detect autoimmune-mediated liver injury. Our data suggest a possible link between the TIM-3/GAL-9 pathway and AIH severity or phenotype, and further investigations of the TIM-3 pathway and AIH pathophysiology is warranted. |
url |
https://doi.org/10.1371/journal.pone.0238540 |
work_keys_str_mv |
AT kiyoshimigita associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT minorunakamura associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT yoshihiroaiba associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT hidekokozuru associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT seigoabiru associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT atsumasakomori associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT yuyafujita associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT junpeitemmoku associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT tomoyukiasano associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT shuzosato associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT makikofuruya associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT atsushinaganuma associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT kanameyoshizawa associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT masaakishimada associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT keisukeario associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT tomohikomannami associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT hiroshikohno associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT toshihikokaneyoshi associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT takuyakomura associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT hiromasaohira associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis AT hiroshiyatsuhashi associationofsolubletcellimmunoglobulindomainandmucin3stim3andmac2bindingproteinglycosylationisomerm2bpgiinpatientswithautoimmunehepatitis |
_version_ |
1714801671194804224 |